Risk-adapted chemoimmunotherapy using brentuximab vedotin and rituximab in children, adolescents, and young adults with newly diagnosed Hodgkin’s lymphoma: a phase II, non-randomized controlled trial
=========================================================================================================================================================================================================

* Jessica Hochberg
* Jaclyn Basso
* Qiuhu Shi
* Liana Klejmont
* Allyson Flower
* Kristina Bortfeld
* Lauren Harrison
* Carmella van de Ven
* Chitti Moorthy
* Humayun Islam
* Perry Gerard
* Stephan Voss
* Mitchell S Cairo